Islatravir is a potent nucleoside reverse transcriptase translocation inhibitor (NRTTI) currently under investigation for the treatment and prevention of HIV-1 infection. By acting as a chain terminator,… Read more




Islatravir is a potent nucleoside reverse transcriptase translocation inhibitor (NRTTI) currently under investigation for the treatment and prevention of HIV-1 infection. By acting as a chain terminator, this molecule inhibits the reverse transcriptase enzyme, effectively blocking viral DNA synthesis and replication. This category provides access to high-quality Islatravir along with a suite of its related substances, including deoxyribose derivatives, phosphate metabolites, and acylated impurities. Pharmaceutical laboratories utilize these reference standards for comprehensive impurity profiling, method validation, and rigorous quality control throughout the drug development lifecycle. By facilitating the accurate identification and quantification of process-related impurities and degradation products, these materials ensure compliance with regulatory standards and support the reliable assessment of drug substance and product stability.